Perspective Therapeutics, Inc. (CATX)

2.785 +0.04 (+1.64%) USD  |  NYAM  |  Dec 24, 12:38
More

Perspective Therapeutics SG&A Expense (TTM): 31.53M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for CATX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Outset Medical, Inc. 92.14M
Xtant Medical Holdings, Inc. 74.03M
VolitionRX Ltd. 13.97M
Catheter Precision, Inc. 12.42M
Picard Medical, Inc. 10.06M